Simultaneous Quantification of Ciprofloxacin, Quinine and 3-hyrdoxyquinine in Human Plasma using a HPLC Method

Adebanjo J. Adegbola, Julius O. Soyinka , Babatunde A. Adeagbo


Malaria has been shown to strongly predispose patients in areas of malaria endemicity to bacteremia with severe outcomes, thus justifying the use of antibiotics in combination with antimalarial therapy in patients with severe malaria. This study describes a High-Performance Liquid Chromatographic (HPLC) method for simultaneous determinations of Ciprofloxacin (CPN), Quinine (QN), and its major metabolite, 3-Hydroxyquinine (3-HQN), in human plasma. Following a simple precipitation with acetonitrile, chromatographic separation was achieved on a reversed-phase Agilent Zorbax (CN) column (5 µm, 150 X 4.6 mm i.d) using a mobile phase consisting of acetonitrile: potassium dihydrogen phosphate (pH = 2.8; 0.02 M) (42:58, v/v). Retention times for CPN, 3-HQN, IS and QN were 2.7, 3.3, 3.6 and 4.9 minutes respectively. The limits of detection and validated lower limits of quantitation were 30 and 70 ng/ml for both QN and 3-HQN while the corresponding values were 50 and 100 ng/ml for CPN, respectively. The new HPLC method here developed, when compared with previous methods for the analysis of either or both drugs is simple, rapid, selective, reproducible and costeffective. It is also suitable for conducting a simultaneous therapeutic monitoring of quinine and ciprofloxacin in patients when concomittantly administered as demonstrated in five healthy volunteers.


3-Hydroxyquinine, Ciprofloxacin, HPLC Analysis, Quinine

Full Text:



WHO World Malaria Report. World Health Organisation.

Geneva: 2014

Scott JA, Berkley JA, Mwangi I, Ochola L, et al. Relation

between falciparum malaria and bacteraemia in Kenyan

children; a population-based, case-control study and longitudinal

study. Lancet. 2011; 378(9799):1316–23.

Were T, Davenport GC, Hittner JB, Ouma C, Vulule MJ,

Ong’echa JM, Perkins DJ. Bacteremia in Kenyan children

presenting with malaria. J Clin Microbiol. 2011; 49(2):671–

Achan J, Ambrose OT, Erhart A, Yeka A, Tibenderana JK,

Frederick NB, Rosenthal PJ, D’Alessandro U. Quinine, an old

anti-malarial drug in a modern world: Role in the treatment

of malaria. Malar J BMC. 2011. DOI: 0.1186/1475-2875-10-

Evan JB, Richard AR, Daren AS, Graham GG, Buttimore

RC, Neill AM, Town GI. The pharmacokinetics of oral

fleroxacin and ciprofloxacin in plasma and sputum during

acute and chronic dosing. Br J Clin Pharmacol. 2000;


Adefurin A, Sammons H, Jacqz-Aigrain E, Choonara I.

Systematic review Ciprofloxacin safety in paediatrics. Arch

Dis Child (ADC). 2011. doi: 10.1136/adc.2010.208843. .

Yeka A, James T, Jane A, Umberto DA, Talisuna AM.

Efficacy of Quinine, Artemether-Lumefantrine and

Dihydroartemisinin-Piperaquine as Rescue Treatment for

Uncomplicated Malaria in Ugandan Children. PLOS ONE.

; 8(1):e53778.

Babalola CP, Bolaji OO, Dixon PA, Ogunbona FA. Column

liquid chromatographic analysis of quinine in human

plasma, saliva and urine. J Chromatogr.1993; 23:151–4.

Soyinka JO, Onyeji CO, Igbinoba SI. Simultaneous liquid

chromatographic analysis of ritonavir, quinine and

-hydroxyquinine in human plasma. J Chromatogr B. 2009;


Pukrittayakamee S, Pitisuttithum P, Zhang H, Jantra A,

Wanwimolruk S, White NJ. Effects of cigarette smoking

on quinine pharmacokinetics in malaria, Eur J Clin

Pharmacol. 2002; 58(5):315–9.

Mirghani RA, Ericsson O, Cook J, Yu P, Gustafsson LL.

Simultaneous determination of quinine and four metabolites

in plasma and urine by high-performance liquid

chromatography. J Chromatogr Biomed Sci Appl. 2001;


Joos B, Ledergerber B, Flepp M, Bettex JD, Luithy R,

Siegenthaler W. Comparison of high-pressure liquid chromatography

and bioassay for determination of ciprofloxacin

in serum and urine. Antimicrob Agents Chemother. 1985;


Chan CY, Lam AW, French GL. Rapid HPLC assay of

fluoroquinolones in clinical specimens. J Antimicrobial

and Chemotherapy. 1989; 23:597–604.

Kamberi M, Tsutsumi K, Kotegawa T, Nakamura T, Nakano

S. Determination of ciprofloxacin in plasma and urine by

HPLC with ultraviolet detection. Clinical Chemistry. 1998;


Davis JD, Aarons L, Houston BJ. Simultaneous assay of

fluoroquinolones and theophylline in plasma by highperformance

liquid chromatography. J Chromatogr. 1993;


Gladys M. Improved high-performance liquid chromatographic

determination of ciprofloxacin and its metabolites

in human specimens. J chromatogr B. 1992; 582:263–7.

Centre for Drug Evaluation and Research. FDA. Validation

of chromatographic methods. 1994.

Gloria W, Fekade BS, Jeffrey L, Jason AR. How do we use

therapeutic drug monitoring to improve outcomes from

severe infections in critically ill patients? BMC Infectious

Diseases. 2014. DOI: 10.1186/1471-2334-14-288

Drago L, De Vecchi E, Mombelli B, Nicola L, Valli M,

Gismondo MB. Activity of levofloxacin and ciprofloxacin

Simultaneous Quantification of Ciprofloxacin, Quinine and 3-hyrdoxyquinine in Human Plasma using a HPLC Method

Vol 8 (1) | 2016 | Asian Journal of Pharmaceutical Research and Health Care

against urinary pathogen. J Antimicrobial Chemotherapy.

; 48:37–45.

Lipman J, Allworth A, Wallis SC. Cerebrospinal Fluid

Penetration of High Doses of Intravenous Ciprofloxacin

in Meningitis. Clinical Infectious Diseases. 2000;


Wanwimolruk S, Sunbhanich M, Pongmarutai M. Effect

of Cimetidine and Ranitidine on the Pharmacokinetics of

Quinine. Br J Clin Pharmacol. 1986; 22:346–50.

Sowunmi A, Salako LA. Effect of dose size on the pharmacokinetics

of orally administered quinine. Eur J Clin

Pharmacol. 1996; 49(5):383–6.

Adegbola AJ, Soyinka JO, Adeagbo BA, Igbinoba SI,

Nathaniel TI. Alteration of the Disposition of Quinine

in Healthy Volunteers after Concurrent Ciprofloxacin

Administration. Am J Ther. 2014. DOI: 10.1097/MJT.


  • There are currently no refbacks.


 Creative Commons 

Listed as Green Publisher